BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37437651)

  • 21. The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition.
    Chen J; Rong N; Liu M; Xu C; Xiong Q; Lei Y
    Toxicol Appl Pharmacol; 2021 Jan; 411():115384. PubMed ID: 33359661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRAF6 regulates proliferation of stromal cells in the transition and peripheral zones of benign prostatic hyperplasia via Akt/mTOR signaling.
    Shi YF; Yu DJ; Jiang CY; Wang XJ; Zhu YP; Zhao RZ; Lv Z; Sun XW
    Prostate; 2018 Feb; 78(3):193-201. PubMed ID: 29171041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown.
    Qian Q; He W; Liu D; Yin J; Ye L; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
    Prostate; 2021 Jun; 81(9):530-542. PubMed ID: 33861464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Honokiol, a constituent of Magnolia species, inhibits adrenergic contraction of human prostate strips and induces stromal cell death.
    Herrmann D; Schreiber A; Ciotkowska A; Strittmatter F; Waidelich R; Stief CG; Gratzke C; Hennenberg M
    Prostate Int; 2014 Sep; 2(3):140-6. PubMed ID: 25325026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of human prostate smooth muscle contraction by the inhibitors of protein kinase C, GF109203X, and Go6983.
    Huang R; Liu Y; Li B; Wang R; Tamalunas A; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
    Prostate; 2022 Jan; 82(1):59-77. PubMed ID: 34633103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The small GTPase RhoA regulates the contraction of smooth muscle tissues by catalyzing the assembly of cytoskeletal signaling complexes at membrane adhesion sites.
    Zhang W; Huang Y; Gunst SJ
    J Biol Chem; 2012 Oct; 287(41):33996-4008. PubMed ID: 22893699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VAT-1 is a novel pathogenic factor of progressive benign prostatic hyperplasia.
    Mori F; Tanigawa K; Endo K; Minamiguchi K; Abe M; Yamada S; Miyoshi K
    Prostate; 2011 Oct; 71(14):1579-86. PubMed ID: 21394740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel role for RhoA GTPase in the regulation of airway smooth muscle contraction.
    Zhang W; Huang Y; Wu Y; Gunst SJ
    Can J Physiol Pharmacol; 2015 Feb; 93(2):129-36. PubMed ID: 25531582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
    Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
    Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3.
    Yu Q; Gratzke C; Wang Y; Herlemann A; Sterr CM; Rutz B; Ciotkowska A; Wang X; Strittmatter F; Stief CG; Hennenberg M
    Br J Pharmacol; 2018 Jun; 175(11):2077-2096. PubMed ID: 29574791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rho kinase collaborates with p21-activated kinase to regulate actin polymerization and contraction in airway smooth muscle.
    Zhang W; Bhetwal BP; Gunst SJ
    J Physiol; 2018 Aug; 596(16):3617-3635. PubMed ID: 29746010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in the expression and functional activities of Myosin II isoforms in human hyperplastic prostate.
    He W; Wang X; Zhan D; Li M; Wang Q; Liu J; Liu D; Fu X; Qian Q; Li Y; Chen P; Zeng G; Wang X; DiSanto ME; Zhang X
    Clin Sci (Lond); 2021 Jan; 135(1):167-183. PubMed ID: 33393635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
    Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
    Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-Adrenergic, Tamsulosin-Insensitive Smooth Muscle Contraction is Sufficient to Replace α
    Hennenberg M; Acevedo A; Wiemer N; Kan A; Tamalunas A; Wang Y; Yu Q; Rutz B; Ciotkowska A; Herlemann A; Strittmatter F; Stief CG; Gratzke C
    Prostate; 2017 May; 77(7):697-707. PubMed ID: 28116771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concentration-dependent alpha
    Huang R; Liu Y; Ciotkowska A; Tamalunas A; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
    Front Pharmacol; 2021; 12():666047. PubMed ID: 34248624
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of the alpha1-adrenergic antagonist, doxazosin, on noradrenaline-induced modulation of cytoskeletal proteins in cultured hyperplastic prostatic stromal cells.
    Smith P; Rhodes NP; Ke Y; Foster CS
    Prostate; 1999 Feb; 38(3):216-27. PubMed ID: 10068346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of alpha1-adrenoceptor antagonists on cultured prostatic smooth muscle cells.
    Boesch ST; Dobler G; Ramoner R; Corvin S; Thurnher M; Bartsch G; Klocker H
    Prostate Suppl; 2000; 9():34-41. PubMed ID: 11056501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
    Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
    Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).
    Lai KP; Huang CK; Fang LY; Izumi K; Lo CW; Wood R; Kindblom J; Yeh S; Chang C
    Mol Endocrinol; 2013 Oct; 27(10):1617-31. PubMed ID: 23893956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the RhoGTPase Cdc42 by ML141 enhances hepatocyte differentiation from human adipose-derived mesenchymal stem cells via the Wnt5a/PI3K/miR-122 pathway: impact of the age of the donor.
    Chaker D; Mouawad C; Azar A; Quilliot D; Achkar I; Fajloun Z; Makdissy N
    Stem Cell Res Ther; 2018 Jun; 9(1):167. PubMed ID: 29921325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.